drugset / Trial / NCT06254781
Luspatercept in Metastatic AGCT of the Ovary
NaSingle-groupOpen-labelTreatment
Summary
This is a single participant study of luspatercept for the treatment of a patient with dult granulosa cell tumor (AGCT) of the ovary.
Timeline
- Start
- 2022-05-30
- Primary completion
- 2022-08-22
- Completion
- 2022-08-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Luspatercept | Protein / enzyme biologic | 1 mg/kg | Subcutaneous |